Joint Formulary & PAD

Optive Fusion (sodium hyaluronate with carmellose sodium and glycerol) - Dry eyes

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Eye drops
Associated Icons :
Restrictions / Comments :
Important
Prescribe by brand. Prescribe on specialist initiation

PAD Profile

ChemicalSubstance :
Optive Fusion (sodium hyaluronate with carmellose sodium and glycerol)
Indication :
Dry eyes
Group Name :
Keywords :
Tear deficiency, dry-eyes, eye lubricants, ocular lubricants, dry eye disease, dry eye syndrome, severe dry eye
Brand Names Include :
Optive Fusion
Important Information :
Severe dry eye
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
2

Committee Recommendations (1)

Severe dry eye

Prescribe by brand.

Optive Fusion 0.1% eye drops.

For use where there is reduced sensations to corneal nerves or the corneal epithelium is slow to heal

Other Indications

Below are listed other indications that Optive Fusion (sodium hyaluronate with carmellose sodium and glycerol) is used to treat.

  • No records returned.